Therefore, the results indicate that BA treatment inhibited DOX-induced cardiac hypertrophy through blocking of GATA-4 activation, the transcriptional regulator for the generation of cardiac hypertrophy. This evidence concerns the gene GATA4 and cardiac hypertrophy.